Can-Fite BioPharma Ltd. (CANF) Ownership

$1.55

north_east $0.03 (1.66%)
Day's range
$1.49
Day's range
$1.57

Can-Fite BioPharma Ltd. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
MORGAN STANLEY 02/14/2023 304,675 $186,766   -4.84% 1.12%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2023 32,739 $20,069   -44.86% 0.12%
FIFTH THIRD BANCORP 01/25/2023 30,000 $18,390   0.00% 0.11%
TWO SIGMA SECURITIES, LLC 02/14/2023 26,985 $16,542   85.16% 0.10%
STIFEL FINANCIAL CORP 02/13/2023 12,000 $7,357   0.00% 0.04%
UBS GROUP AG 02/08/2023 8,712 $5,314   -49.82% 0.03%
NATIONAL BANK OF CANADA /FI/ 01/24/2023 6,000 $3,666   0.00% 0.02%
CITIGROUP INC 02/09/2023 5,535 $3,393   0.00% 0.02%
FEDERATION DES CAISSES DESJARDINS DU QUEBEC 08/15/2024 533 $327   0.00% 0.00%
BNP PARIBAS ARBITRAGE, SNC 02/14/2023 400 $245   100.00% 0.00%
TD WATERHOUSE CANADA INC. 11/13/2023 203 $164   0.00% 0.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 01/30/2023 0 $0   0.00% 0.00%
VIRTU FINANCIAL LLC 02/15/2023 0 $0   -100.00% 0.00%

Can-Fite BioPharma Ltd.institutional Ownership - FAQ's

Who are the largest shareholders of CANF shares?

During the previous two years, 1 institutional investors and hedge funds held shares of Can-Fite BioPharma Ltd.. The most heavily invested institutionals were:

American Portfolios Advisors: 1,100

What percentage of Can-Fite BioPharma Ltd. stock is owned by institutional investors?

1.57% of Can-Fite BioPharma Ltd. stock is owned by institutional investors.

How much institutional buying is happening at CANF ?

Institutional investors have bought a total of 1,100 shares in the last 24 months. This purchase volume represents approximately $1,705 in transactions.